Silexion Therapeutics Ltd. (SLXN) vs Zhongchao Inc. (ZCMD)
A side-by-side comparison of Silexion Therapeutics Ltd. and Zhongchao Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SLXN
Silexion Therapeutics Ltd.
$0.26HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
ZCMD
Zhongchao Inc.
$1.78HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — SLXN vs ZCMD
growth of $100 · dividends reinvested · last 2ySLXN -100.0% (-99.0%/yr)ZCMD -99.9% (-96.9%/yr)ZCMD compounded faster over this window
Log scale — wide-divergence pair
SLXN ZCMD
SLXN vs ZCMD: by the numbers
- •SLXN is the larger company ($109735 vs $30924 market cap).
- •Both run net losses; SLXN's is the smaller (0.00% vs -55.47% net margin).
Metrics side by side
Valuation
| Metric | SLXN | ZCMD |
|---|---|---|
| P/B ratio | 2.49 | 0.00 |
Profitability
| Metric | SLXN | ZCMD |
|---|---|---|
| Gross margin | 0.00% | 42.47% |
| Operating margin | 0.00% | -54.43% |
| Net margin | 0.00% | -55.47% |
| ROE | -31722.73% | -33.87% |
| ROIC | N/A | -27.17% |
Growth (annualized)
| Metric | SLXN | ZCMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -8.76% |
| Total return CAGR (5Y) | N/A | -84.76% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.